Quick Answer
AdaptHealth Corp. reported Net Income Loss of -$70.79 million for the year ending 2025.
- AdaptHealth Corp. showed a decrease of -178.3% in Net Income Loss from 2024 to 2025.
- This data is from AdaptHealth Corp.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $220.3 thousand | Q2 2018: $689.8 thousand | Q3 2018: $518.3 thousand | Q1 2019: -$5.80 million | Q2 2019: -$2.08 million | Q3 2019: -$3.69 million | Q1 2020: -$34.55 million | Q2 2020: $4.47 million | Q3 2020: -$51.04 million | Q1 2021: -$3.97 million | Q2 2021: $79.11 million | Q3 2021: $58.09 million | Q1 2022: $41.75 million | Q2 2022: $14.03 million | Q3 2022: $16.12 million | Q1 2023: $15.71 million | Q2 2023: $13.98 million | Q3 2023: -$454.08 million | Q1 2024: -$2.13 million | Q2 2024: $19.44 million | Q3 2024: $22.86 million | Q1 2025: -$7.21 million | Q2 2025: $14.67 million | Q3 2025: $24.51 million.
- Over the full 9 years of available data (2017 to 2025), AdaptHealth Corp.'s Net Income Loss has declined by 10,215,484.4%.
- Historical annual values: Fiscal year 2025: -$70.79 million | Fiscal year 2024: $90.42 million | Fiscal year 2023: -$678.90 million | Fiscal year 2022: $69.32 million | Fiscal year 2021: $156.18 million | Fiscal year 2020: -$161.63 million | Fiscal year 2019: -$21.34 million | Fiscal year 2018: $23.26 million | Fiscal year 2017: -$693.00.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: